Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 716
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07570979 A Study to Investigate the Safety and Tolerability of Oral INR731 Singl… |
INR731 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Australia, Canada, Germany, Italy, Jap… | 2026-05-25 → 2030-06-03 | Ouvrir |
| NCT07063745 MountainTAP-29 — A Study to Compare the Combination of Navlimetostat (B… |
BMS-986504 | Cancer | Phase 2/3 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Argentina, Australia, Austria, Belgium… | 2026-01-02 → 2031-08-12 | Ouvrir |
| NCT06440993 Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extra- and… |
Gemcitabine | Cancer | Phase 2 | RECRUITING | En attente / non publié | University of Louisville | Germany · Evangelisches Krankenhaus Düsseldorf, Düsse… | 2024-08-23 → 2028-04 | Ouvrir |
| NCT07209865 68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head… |
68Ga-P16-093 | Cancer | Phase 2 | COMPLETED | En attente / non publié | First Affiliated Hospital of Fuji… | China · Department of Nuclear Medicine, First Affilia… | 2024-10-01 → 2026-06-20 | Ouvrir |
| NCT06561386 RELATIVITY1093 — A Study to Compare the Efficacy of Nivolumab and Relat… |
Nivolumab | Cancer | Phase 3 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Argentina, Australia, Austria, Belgium… | 2024-10-07 → 2032-08-04 | Ouvrir |
| NCT06634875 Isunakinra Alone and in Combination With Pembrolizumab in Patients With… |
isunakinra | Cancer | Phase 2 | RECRUITING | En attente / non publié | Buzzard Pharmaceuticals | United States · Emory University, Atlanta, United Sta… | 2025-01-30 → 2027-12-31 | Ouvrir |
| NCT07796373 Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic … |
Nemtabrutinib | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | National Heart, Lung, and Blood I… | United States · National Institutes of Health Clinica… | 2026-10-28 → 2031-12-01 | Ouvrir |
| NCT07524530 Stem Cell Transplantation for Participants With Germline RUNX1 Associat… |
Cyclophosphamide | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Kite, A Gilead Company | United States · National Institutes of Health Clinica… | 2026-10-28 → 2036-06-01 | Ouvrir |
| NCT07756840 Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respirat… |
PRGN-2012 | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-10-28 → 2030-07-01 | Ouvrir |
| NCT07293351 A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig… |
Pumitamig | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | BioNTech SE | United States, Argentina, Australia, Canada, Chile, C… | 2026-03-26 → 2031-11-26 | Ouvrir |
| NCT03711032 Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Baci… |
Pembrolizumab | Parkinson | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Australia, Austria, Belgium, Brazil, C… | 2018-12-24 → 2034-11-20 | Ouvrir |
| NCT00004179 Combination Chemotherapy With or Without Rituximab in Treating Patients… |
Rituximab | SEP | Phase 3 | COMPLETED | En attente / non publié | Claudio Gobbi | Australia, Belgium, Canada, Denmark, Egypt, France, H… | 1999-05 → 2017-07-19 | Ouvrir |
| NCT01791998 Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Ther… |
magnetic resonance thermal imaging | Cancer | Non applicable | WITHDRAWN | En attente / non publié | University of Chicago | United States · University of Chicago Comprehensive C… | 2012-08 → 2014-06 | Ouvrir |
| NCT07238894 A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-su… |
Combined Cryoablation and Thermal… | Cancer | Non applicable | RECRUITING | En attente / non publié | Peking University People's Hospit… | China · Peking University People's Hospital, Beijing,… | 2026-03-03 → 2028-10-01 | Ouvrir |
| NCT00712712 MEDOR — Morphine After Radiofrequency Ablation of Painful Bone Metastas… |
Acetaminophen | Cancer | Phase 2 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | France · Institute Bergonié, Bordeaux, France | 2007-12-24 → 2016-03-16 | Ouvrir |
| NCT04619472 BRONC-RFⅡ — Safety and Effectiveness of Radiofrequency Ablation System … |
Pulmonary Radiofrequency Ablation… | Cancer | Non applicable | COMPLETED | En attente / non publié | Hangzhou Broncus Medical Co., Ltd. | China · Shanghai Chest hospital, Shanghai, China | Th… | 2021-01-07 → 2023-03-27 | Ouvrir |
| NCT01990521 Prostate Screening Study Using MRI in BRCA Carriers |
MS3TMRI / TRUS Guided Biopsy | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Toronto Sunnybrook Regional Cance… | Canada · Sunnybrook Odette Cancer Centre, Toronto, Ca… | 2014-01 → 2026-09 | Ouvrir |
| NCT04116320 AM-003 — Focused Ultrasound Ablation and PD-1 Antibody Blockade in Adva… |
Echopulse | Cancer | Phase 1 | TERMINATED | En attente / non publié | The University of Hong Kong | United States · University of Virginia, Charlottesvil… | 2019-11-21 → 2023-08-15 | Ouvrir |
| NCT07142876 Evaluation Of Liver Resection Using Harmonic Scalpel Versus Cavitron Ul… |
Liver resection Cavitron Ultrason… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Sohag University | Non communiqué | 2025-08-22 → 2026-12-30 | Ouvrir |
| NCT07873606 histo-pancreas — Histotripsy x Pancreatic Cancer |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | RECRUITING | En attente / non publié | Northwell Health | Hong Kong · The University of Hong Kong, Hong Kong, H… | 2026-03-31 → 2028-01-25 | Ouvrir |
| NCT07878377 SAFE-MRI — Screening and the Future of Enhanced MRI for Early Breast Ca… |
Breast MRI Screening | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Radboud University Medical Center | Non communiqué | 2027-01-01 → 2031-12 | Ouvrir |
| NCT06995872 Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide … |
rhIL-15 | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2025-10-21 → 2029-06-01 | Ouvrir |
| NCT06576921 Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadj… |
Serplulimab Combined With Chemoth… | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Xijing Hospital | China · Department of Digestive surgery, Xijing Hospi… | 2024-11-15 → 2026-10-30 | Ouvrir |
| NCT07493447 Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent… |
Panitumumab-IRDye800 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Eben Rosenthal | United States · Vanderbilt University Medical Center,… | 2026-07-07 → 2031-06 | Ouvrir |
| NCT07460765 Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head an… |
Nivo800 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Vanderbilt-Ingram Cancer Center | United States · Vanderbilt University Medical Center,… | 2026-07-03 → 2031-04 | Ouvrir |